Symbol
| KRT19
| contributors: mct/npt - updated : 31-03-2016
|
HGNC name
| keratin 19
|
HGNC id
| 6436
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --other
|  
|
aberrantly expressed in hepatocellular carcinoma expressing having a higher rate of recurrence | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| both KRT19 and ANXA8 mRNA may be useful markers for detecting lymph node metastases in OSCC (oral squamous cell carcinoma) patients | |
sensitive marker to identify yolk sac tumours of the testis and to distinguish them from other germ cell tumours, especially seminomas and embryonic carcinomas | |
used as a biomarker for the detection of disseminated tumors | |
KRT19 expression can be used as a prognostic marker in breast cancer | |
high levels of fecal KRT19 mRNA represent a potential marker for colorectal malignancy and for aggressive treatment of younger CRC patients | Therapy target
| | |
| tibialis anterior (TA) muscles of mice lacking keratin 19 (K19) lose costameres, accumulate mitochondria under the sarcolemma, and generate lower specific tension than controls |